Skip to main content
Equibles

Legal & General Group Plc

Position in ZYME — Zymeworks Inc.

CIK 764068 London, X0
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,128,201
+$471,928 QoQ
Shares Held
43,160
+64.7% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 203 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. ZYME ranks #107 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in ZYME

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,128,201 43,160
2026-03-31 $656,273 26,209
2025-12-31 $846,481 32,149
2025-09-30 $484,541 28,369
2025-06-30 $549,225 43,763
2025-03-31 $557,268 46,790
2024-12-31 $689,279 47,082
2024-09-30 $496,615 39,571
2024-06-30 $302,444 35,540
2024-03-31 $420,147 39,938
2023-12-31 $417,761 40,208
2023-09-30 $229,976 36,274
2023-06-30 $347,465 40,216
2023-03-31 $175,032 19,362